{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T09:34:55Z","timestamp":1787564095779,"version":"build-2736575974"},"reference-count":106,"publisher":"Elsevier BV","issue":"5","content-domain":{"domain":["cell.com","bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Molecular Medicine"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.molmed.2013.12.001","type":"journal-article","created":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T09:11:51Z","timestamp":1393665111000},"page":"271-281","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":85,"title":["Nanomedicine-based strategies for treatment of atherosclerosis"],"prefix":"10.1016","volume":"20","author":[{"given":"Maximilian","family":"Schiener","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Hossann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana R.","family":"Viola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Almudena","family":"Ortega-Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten","family":"Lauber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars H.","family":"Lindner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Soehnlein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molmed.2013.12.001_bib0005","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/ng.269","article-title":"Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts","volume":"41","author":"Aulchenko","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.molmed.2013.12.001_bib0010","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/ng.76","article-title":"Newly identified loci that influence lipid concentrations and risk of coronary artery disease","volume":"40","author":"Willer","year":"2008","journal-title":"Nat. Genet."},{"key":"10.1016\/j.molmed.2013.12.001_bib0015","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.1111\/j.1582-4934.2009.00965.x","article-title":"Functional alterations of myeloid cell subsets in hyperlipidaemia: relevance for atherosclerosis","volume":"13","author":"Soehnlein","year":"2009","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.molmed.2013.12.001_bib0020","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.bbalip.2011.08.003","article-title":"Anti-atherogenic mechanisms of high density lipoprotein: effects on myeloid cells","volume":"1821","author":"Murphy","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.molmed.2013.12.001_bib0025","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1038\/nm.2538","article-title":"Atherosclerosis: current pathogenesis and therapeutic options","volume":"17","author":"Weber","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.molmed.2013.12.001_bib0030","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/emmm.201201717","article-title":"Distinct functions of chemokine receptor axes in the atherogenic mobilization and recruitment of classical monocytes","volume":"5","author":"Soehnlein","year":"2013","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.molmed.2013.12.001_bib0035","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1161\/CIRCULATIONAHA.110.961714","article-title":"Hyperlipidemia-triggered neutrophilia promotes early atherosclerosis","volume":"122","author":"Drechsler","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.molmed.2013.12.001_bib0040","doi-asserted-by":"crossref","first-page":"11779","DOI":"10.1073\/pnas.0403259101","article-title":"Emigration of monocyte-derived cells from atherosclerotic lesions characterizes regressive, but not progressive, plaques","volume":"101","author":"Llodr\u00e1","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.molmed.2013.12.001_bib0045","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1038\/nm.3258","article-title":"Local proliferation dominates lesional macrophage accumulation in atherosclerosis","volume":"19","author":"Robbins","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.molmed.2013.12.001_bib0050","doi-asserted-by":"crossref","unstructured":"Silvestre-Roig, C. et al. Atherosclerotic plaque destabilization: mechanisms, models, and therapeutic strategies. Circ. Res. http:\/\/dx.doi.org\/10.1161\/CIRCRESAHA.114.302355","DOI":"10.1161\/CIRCRESAHA.114.302355"},{"key":"10.1016\/j.molmed.2013.12.001_bib0055","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/nrd3578","article-title":"Perspectives and opportunities for nanomedicine in the management of atherosclerosis","volume":"10","author":"Lobatto","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.molmed.2013.12.001_bib0060","doi-asserted-by":"crossref","first-page":"899","DOI":"10.2217\/nnm.12.57","article-title":"Emerging engineered magnetic nanoparticulate probes for molecular MRI of atherosclerosis: how far have we come?","volume":"7","author":"Kanwar","year":"2012","journal-title":"Nanomedicine (Lond.)"},{"key":"10.1016\/j.molmed.2013.12.001_bib0065","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.maturitas.2011.12.014","article-title":"Nanomedicine for the prevention, treatment and imaging of atherosclerosis","volume":"73","author":"Psarros","year":"2012","journal-title":"Maturitas"},{"key":"10.1016\/j.molmed.2013.12.001_bib0070","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jconrel.2012.12.013","article-title":"Biocompatibility of engineered nanoparticles for drug delivery","volume":"166","author":"Naahidi","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.molmed.2013.12.001_bib0075","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/wnan.145","article-title":"Polymer-based therapeutics: nanoassemblies and nanoparticles for management of atherosclerosis","volume":"3","author":"Lewis","year":"2011","journal-title":"WIREs Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.molmed.2013.12.001_bib0080","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1161\/ATVBAHA.113.301290","article-title":"Photodynamic therapy using a protease-mediated theranostic agent reduces cathepsin-B activity in mouse atheromata in vivo","volume":"33","author":"Shon","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.molmed.2013.12.001_bib0085","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1002\/smll.201000596","article-title":"A light-activated theranostic nanoagent for targeted macrophage ablation in inflammatory atherosclerosis","volume":"6","author":"McCarthy","year":"2010","journal-title":"Small"},{"key":"10.1016\/j.molmed.2013.12.001_bib0090","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1177\/1358863X10392474","article-title":"Emerging diagnostic and therapeutic molecular imaging applications in vascular disease","volume":"16","author":"Eraso","year":"2011","journal-title":"Vasc. Med."},{"key":"10.1016\/j.molmed.2013.12.001_bib0095","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1161\/ATVBAHA.108.165530","article-title":"Optical and multimodality molecular imaging: insights into atherosclerosis","volume":"29","author":"Jaffer","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.molmed.2013.12.001_bib0100","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v26.i6.10","article-title":"Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinic","volume":"26","author":"Puri","year":"2009","journal-title":"Crit. Rev. Ther. Drug Carrier Syst."},{"key":"10.1016\/j.molmed.2013.12.001_bib0105","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jconrel.2009.05.036","article-title":"Liposome drugs\u2019 loading efficiency: a working model based on loading conditions and drug's physicochemical properties","volume":"139","author":"Zucker","year":"2009","journal-title":"J. Control. Release"},{"key":"10.1016\/j.molmed.2013.12.001_bib0110","first-page":"111","article-title":"Factors affecting drug release from liposomes","volume":"13","author":"Lindner","year":"2010","journal-title":"Curr. Opin. Drug Discov. Devel."},{"key":"10.1016\/j.molmed.2013.12.001_bib0115","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0927-7765(99)00156-3","article-title":"Stealth\u201d corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption","volume":"18","author":"Gref","year":"2000","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.molmed.2013.12.001_bib0120","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0005-2736(93)90351-Y","article-title":"Molecular mechanism of the lipid vesicle longevity in vivo","volume":"1146","author":"Blume","year":"1993","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.molmed.2013.12.001_bib0125","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ejps.2005.08.002","article-title":"In vivo tumor targeting of tumor necrosis factor-\u03b1-loaded stealth nanoparticles: effect of MePEG molecular weight and particle size","volume":"27","author":"Fang","year":"2006","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.molmed.2013.12.001_bib0130","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1021\/nn101937h","article-title":"Effect of core diameter, surface coating, and PEG chain length on the biodistribution of persistent luminescence nanoparticles in mice","volume":"5","author":"Maldiney","year":"2011","journal-title":"ACS Nano"},{"key":"10.1016\/j.molmed.2013.12.001_bib0135","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jconrel.2012.07.013","article-title":"Anticancer nanomedicine and tumor vascular permeability: where is the missing link?","volume":"164","author":"Taurin","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.molmed.2013.12.001_bib0140","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/j.jacc.2008.12.056","article-title":"Thin-walled microvessels in human coronary atherosclerotic plaques show incomplete endothelial junctions relevance of compromised structural integrity for intraplaque microvascular leakage","volume":"53","author":"Sluimer","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.molmed.2013.12.001_bib0145","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1161\/CIRCULATIONAHA.112.092098","article-title":"Noninvasive magnetic resonance imaging evaluation of endothelial permeability in murine atherosclerosis using an albumin-binding contrast agent","volume":"126","author":"Phinikaridou","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.molmed.2013.12.001_bib0150","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.4155\/tde.13.80","article-title":"pH-sensitive liposomes for drug delivery in cancer treatment","volume":"4","author":"Ferreira","year":"2013","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.molmed.2013.12.001_bib0155","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1001\/jama.282.21.2035","article-title":"Hemodynamic shear stress and its role in atherosclerosis","volume":"282","author":"Malek","year":"1999","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.molmed.2013.12.001_bib0160","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/nnano.2012.84","article-title":"Shear-stress sensitive lenticular vesicles for targeted drug delivery","volume":"7","author":"Holme","year":"2012","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.molmed.2013.12.001_bib0165","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1126\/science.1217815","article-title":"Shear-activated nanotherapeutics for drug targeting to obstructed blood vessels","volume":"337","author":"Korin","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.molmed.2013.12.001_bib0170","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jconrel.2012.04.041","article-title":"Hyperthermia-triggered drug delivery from temperature-sensitive liposomes using MRI-guided high intensity focused ultrasound","volume":"161","author":"Gr\u00fcll","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.molmed.2013.12.001_bib0175","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1046\/j.1365-201X.2001.00882.x","article-title":"Adhesion molecules and atherogenesis","volume":"173","author":"Huo","year":"2001","journal-title":"Acta Physiol. Scand."},{"key":"10.1016\/j.molmed.2013.12.001_bib0180","article-title":"Endothelial JAM-A guides monocytes into flow-dependent predilection sites of atherosclerosis","author":"Schmitt","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.molmed.2013.12.001_bib0185","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/nbt.1989","article-title":"Therapeutic siRNA silencing in inflammatory monocytes in mice","volume":"29","author":"Leuschner","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.molmed.2013.12.001_bib0190","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1161\/CIRCULATIONAHA.112.000116","article-title":"Monocyte-directed RNAi targeting CCR2 improves infarct healing in atherosclerosis-prone mice","volume":"127","author":"Majmudar","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.molmed.2013.12.001_bib0195","doi-asserted-by":"crossref","first-page":"9815","DOI":"10.1073\/pnas.0903369106","article-title":"Targeting atherosclerosis by using modular, multifunctional micelles","volume":"106","author":"Peters","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.molmed.2013.12.001_bib0200","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1194\/jlr.P800003-JLR200","article-title":"Safety, pharmacokinetics, and pharmacodynamics of oral apoA-I mimetic peptide D-4F in high-risk cardiovascular patients","volume":"49","author":"Bloedon","year":"2008","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.molmed.2013.12.001_bib0205","doi-asserted-by":"crossref","first-page":"9445","DOI":"10.1073\/pnas.1301929110","article-title":"Biodegradable synthetic high-density lipoprotein nanoparticles for atherosclerosis","volume":"110","author":"Marrache","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.molmed.2013.12.001_bib0210","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1021\/nl1041947","article-title":"Biomimetic high density lipoprotein nanoparticles for nucleic acid delivery","volume":"11","author":"McMahon","year":"2011","journal-title":"Nano Lett."},{"key":"10.1016\/j.molmed.2013.12.001_bib0215","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jcin.2008.08.023","article-title":"Formulation of nanoparticle-eluting stents by a cationic electrodeposition coating technology: efficient nano-drug delivery via bioabsorbable polymeric nanoparticle-eluting stents in porcine coronary arteries","volume":"2","author":"Nakano","year":"2009","journal-title":"JACC Cardiovasc. Interv."},{"key":"10.1016\/j.molmed.2013.12.001_bib0220","doi-asserted-by":"crossref","first-page":"103ra98","DOI":"10.1126\/scitranslmed.3002531","article-title":"Neutrophil-derived cathelicidin protects from neointimal hyperplasia","volume":"3","author":"Soehnlein","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.molmed.2013.12.001_bib0225","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nature04688","article-title":"RNAi-mediated gene silencing in non-human primates","volume":"441","author":"Zimmermann","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2013.12.001_bib0230","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1161\/CIRCULATIONAHA.111.057406","article-title":"Gene inactivation of proprotein convertase subtilisin\/kexin type 9 reduces atherosclerosis in mice","volume":"125","author":"Denis","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.molmed.2013.12.001_bib0235","doi-asserted-by":"crossref","first-page":"11915","DOI":"10.1073\/pnas.0805434105","article-title":"Therapeutic RNAi targeting PCSK9 acutely lowers plasma cholesterol in rodents and LDL cholesterol in nonhuman primates","volume":"105","author":"Frank-Kamenetsky","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.molmed.2013.12.001_bib0240","article-title":"Effect of an RNA interference drug on the synthesis of proprotein convertase subtilisin\/kexin type 9 (PCSK9) and the concentration of serum LDL cholesterol in healthy volunteers: a randomised, single-blind, placebo-controlled, phase 1 trial","author":"Fitzgerald","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.molmed.2013.12.001_bib0245","doi-asserted-by":"crossref","first-page":"4138","DOI":"10.1172\/JCI57559","article-title":"ApoE regulates hematopoietic stem cell proliferation, monocytosis, and monocyte accumulation in atherosclerotic lesions in mice","volume":"121","author":"Murphy","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molmed.2013.12.001_bib0250","first-page":"3900","article-title":"Combined deficiency of ABCA1 and ABCG1 promotes foam cell accumulation and accelerates atherosclerosis in mice","volume":"117","author":"Yvan-Charvet","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molmed.2013.12.001_bib0255","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCRESAHA.113.301112","article-title":"Pegylation of HDL decreases plasma clearance and enhances anti-atherogenic activity","author":"Murphy","year":"2013","journal-title":"Circ. Res."},{"key":"10.1016\/j.molmed.2013.12.001_bib0260","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.atherosclerosis.2011.10.006","article-title":"Recombinant HDLMilano exerts greater anti-inflammatory and plaque stabilizing properties than HDLwild-type","volume":"220","author":"Ibanez","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.molmed.2013.12.001_bib0265","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1258\/ebm.2010.009320","article-title":"Synthetic dimyristoylphosphatidylcholine liposomes assimilating into high-density lipoprotein promote regression of atherosclerotic lesions in cholesterol-fed rabbits","volume":"235","author":"Cho","year":"2010","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.molmed.2013.12.001_bib0270","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1194\/jlr.M300133-JLR200","article-title":"Macrophage cholesterol efflux and the active domains of serum amyloid A 2.1","volume":"44","author":"Kisilevsky","year":"2003","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.molmed.2013.12.001_bib0275","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1194\/jlr.M500191-JLR200","article-title":"Peptides derived from serum amyloid A prevent, and reverse, aortic lipid lesions in apoE\u2212\/\u2212 mice","volume":"46","author":"Tam","year":"2005","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.molmed.2013.12.001_bib0280","doi-asserted-by":"crossref","first-page":"8319","DOI":"10.1016\/j.biomaterials.2011.07.039","article-title":"Dual use of amphiphilic macromolecules as cholesterol efflux triggers and inhibitors of macrophage athero-inflammation","volume":"32","author":"Iverson","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.molmed.2013.12.001_bib0285","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/adma.201103348","article-title":"Kinetically assembled nanoparticles of bioactive macromolecules exhibit enhanced stability and cell-targeted biological efficacy","volume":"24","author":"York","year":"2012","journal-title":"Adv. Mater."},{"key":"10.1016\/j.molmed.2013.12.001_bib0290","article-title":"A statin-loaded reconstituted high-density lipoprotein nanoparticle to treat atherosclerotic plaque inflammation","author":"Duivenvoorden","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2013.12.001_bib0295","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1080\/10611860500159030","article-title":"Efficient drug delivery to atherosclerotic lesions and the antiatherosclerotic effect by dexamethasone incorporated into liposomes in atherogenic mice","volume":"13","author":"Chono","year":"2005","journal-title":"J. Drug Target."},{"key":"10.1016\/j.molmed.2013.12.001_bib0300","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1021\/mp100309y","article-title":"Multimodal clinical imaging to longitudinally assess a nanomedical anti-inflammatory treatment in experimental atherosclerosis","volume":"7","author":"Lobatto","year":"2010","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.molmed.2013.12.001_bib0305","doi-asserted-by":"crossref","first-page":"21444","DOI":"10.1073\/pnas.1217972110","article-title":"Painting blood vessels and atherosclerotic plaques with an adhesive drug depot","volume":"109","author":"Kastrup","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.molmed.2013.12.001_bib0310","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1038\/cdd.2013.82","article-title":"Milk fat globule-EGF factor 8 mediates the enhancement of apoptotic cell clearance by glucocorticoids","volume":"20","author":"Lauber","year":"2013","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.molmed.2013.12.001_bib0315","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nri2470","article-title":"Annexin A1 and glucocorticoids as effectors of the resolution of inflammation","volume":"9","author":"Perretti","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.molmed.2013.12.001_bib0320","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/emmm.201202382","article-title":"Resolution of inflammation: an integrated view","volume":"5","author":"Ortega-G\u00f3mez","year":"2013","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.molmed.2013.12.001_bib0325","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1303377110","article-title":"Development and in vivo efficacy of targeted polymeric inflammation-resolving nanoparticles","author":"Kamaly","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.molmed.2013.12.001_bib0330","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1172\/JCI65831","article-title":"Annexin A1, formyl peptide receptor, and NOX1 orchestrate epithelial repair","volume":"123","author":"Leoni","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molmed.2013.12.001_bib0335","doi-asserted-by":"crossref","first-page":"5543","DOI":"10.4049\/jimmunol.1003865","article-title":"Cutting edge: humanized nano-proresolving medicines mimic inflammation-resolution and enhance wound healing","volume":"186","author":"Norling","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.molmed.2013.12.001_bib0340","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/j.1476-5381.2010.00950.x","article-title":"Lipoxin A4 attenuates zymosan-induced arthritis by modulating endothelin-1 and its effects","volume":"161","author":"Conte","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.molmed.2013.12.001_bib0345","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1161\/01.ATV.0000235724.11299.76","article-title":"Endothelial \u03b1\u03bd\u03b23 integrin-targeted fumagillin nanoparticles inhibit angiogenesis in atherosclerosis","volume":"26","author":"Winter","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.molmed.2013.12.001_bib0350","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1161\/ATVBAHA.112.301162","article-title":"CXCL12 promotes the stabilization of atherosclerotic lesions mediated by smooth muscle progenitor cells in Apoe-deficient mice","volume":"33","author":"Akhtar","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.molmed.2013.12.001_bib0355","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1021\/mp900116r","article-title":"Delivery of stem cells to porcine arterial wall with echogenic liposomes conjugated to antibodies against CD34 and intercellular adhesion molecule-1","volume":"7","author":"Herbst","year":"2010","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.molmed.2013.12.001_bib0360","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1161\/01.CIR.0000032141.31476.15","article-title":"Sustained reduction of in-stent neointimal growth with the use of a novel systemic nanoparticle paclitaxel","volume":"106","author":"Kolodgie","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.molmed.2013.12.001_bib0365","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1038\/gt.2010.69","article-title":"Local arterial nanoparticle delivery of siRNA for NOX2 knockdown to prevent restenosis in an atherosclerotic rat model","volume":"17","author":"Li","year":"2010","journal-title":"Gene Ther."},{"key":"10.1016\/j.molmed.2013.12.001_bib0370","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.jacc.2009.04.039","article-title":"Nitric oxide-loaded echogenic liposomes for nitric oxide delivery and inhibition of intimal hyperplasia","volume":"54","author":"Huang","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.molmed.2013.12.001_bib0375","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1161\/ATVBAHA.108.170662","article-title":"Site-specific targeting of nanoparticle prednisolone reduces in-stent restenosis in a rabbit model of established atheroma","volume":"28","author":"Joner","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.molmed.2013.12.001_bib0380","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1161\/ATVBAHA.107.156281","article-title":"Intramural delivery of rapamycin with \u03b1v\u03b23-targeted paramagnetic nanoparticles inhibits stenosis after balloon injury","volume":"28","author":"Cyrus","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.molmed.2013.12.001_bib0385","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jconrel.2013.07.026","article-title":"The accelerated blood clearance (ABC) phenomenon: clinical challenge and approaches to manage","volume":"172","author":"Abu Lila","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.molmed.2013.12.001_bib0390","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nnano.2007.223","article-title":"Immunological properties of engineered nanomaterials","volume":"2","author":"Dobrovolskaia","year":"2007","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.molmed.2013.12.001_bib0395","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.ijpharm.2012.07.049","article-title":"Accelerated blood clearance of PEGylated liposomes containing doxorubicin upon repeated administration to dogs","volume":"436","author":"Suzuki","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.molmed.2013.12.001_bib0400","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1016\/j.addr.2012.07.005","article-title":"A porcine model of complement-mediated infusion reactions to drug carrier nanosystems and other medicines","volume":"64","author":"Szebeni","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.molmed.2013.12.001_bib0405","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1289\/ehp.1002508","article-title":"Long-term inhalation exposure to nickel nanoparticles exacerbated atherosclerosis in a susceptible mouse model","volume":"119","author":"Kang","year":"2011","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.molmed.2013.12.001_bib0410","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1161\/01.CIR.0000070540.80780.92","volume":"107","author":"Hedman","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.molmed.2013.12.001_bib0415","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1001\/jama.290.17.2292","article-title":"Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial","volume":"290","author":"Nissen","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.molmed.2013.12.001_bib0420","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/clc.20066","article-title":"Systemic nanoparticle paclitaxel (nab-paclitaxel) for in-stent restenosis I (SNAPIST-I): a first-in-human safety and dose-finding study","volume":"30","author":"Margolis","year":"2007","journal-title":"Clin. Cardiol."},{"key":"10.1016\/j.molmed.2013.12.001_bib0425","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.ahj.2012.10.023","article-title":"Targeted anti-inflammatory systemic therapy for restenosis: the Biorest Liposomal Alendronate with Stenting sTudy (BLAST)\u2014a double blind, randomized clinical trial","volume":"165","author":"Banai","year":"2013","journal-title":"Am. Heart J."},{"key":"10.1016\/j.molmed.2013.12.001_bib0430","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacc.2013.07.081","article-title":"Mipomersen, an apolipoprotein B synthesis inhibitor, reduces atherogenic lipoproteins in patients with severe hypercholesterolemia at high cardiovascular risk: a randomized, double-blind, placebo-controlled trial","author":"Thomas","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.molmed.2013.12.001_bib0435","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1161\/CIRCULATIONAHA.112.104125","article-title":"Apolipoprotein B synthesis inhibition with mipomersen in heterozygous familial hypercholesterolemia: results of a randomized, double-blind, placebo-controlled trial to assess efficacy and safety as add-on therapy in patients with coronary artery disease","volume":"126","author":"Stein","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.molmed.2013.12.001_bib0440","first-page":"393","article-title":"Antibody-labeled liposomes for CT imaging of atherosclerotic plaques: in vitro investigation of an anti-ICAM antibody-labeled liposome containing iohexol for molecular imaging of atherosclerotic plaques via computed tomography","volume":"36","author":"Danila","year":"2009","journal-title":"Tex. Heart Inst. J."},{"key":"10.1016\/j.molmed.2013.12.001_bib0445","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1477-3155-10-25","article-title":"Targeting of ICAM-1 on vascular endothelium under static and shear stress conditions using a liposomal Gd-based MRI contrast agent","volume":"10","author":"Paulis","year":"2012","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.molmed.2013.12.001_bib0450","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1124\/jpet.105.098970","article-title":"Endothelial targeting of high-affinity multivalent polymer nanocarriers directed to intercellular adhesion molecule 1","volume":"317","author":"Muro","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.molmed.2013.12.001_bib0455","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1038\/mt.2008.127","article-title":"Control of endothelial targeting and intracellular delivery of therapeutic enzymes by modulating the size and shape of ICAM-1-targeted carriers","volume":"16","author":"Muro","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.molmed.2013.12.001_bib0460","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1021\/mp100393j","article-title":"Calcium condensed LABL-TAT complexes effectively target gene delivery to ICAM-1 expressing cells","volume":"8","author":"Khondee","year":"2011","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.molmed.2013.12.001_bib0465","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1021\/bc700227z","article-title":"PLGA nanoparticle\u2212peptide conjugate effectively targets intercellular cell-adhesion molecule-1","volume":"19","author":"Zhang","year":"2008","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.molmed.2013.12.001_bib0470","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1124\/jpet.111.185579","article-title":"A fibrinogen-derived peptide provides intercellular adhesion molecule-1-specific targeting and intraendothelial transport of polymer nanocarriers in human cell cultures and mice","volume":"340","author":"Garnacho","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.molmed.2013.12.001_bib0475","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1161\/01.RES.0000155722.17881.dd","article-title":"Detection of vascular adhesion molecule-1 expression using a novel multimodal nanoparticle","volume":"96","author":"Kelly","year":"2005","journal-title":"Circ. Res."},{"key":"10.1016\/j.molmed.2013.12.001_bib0480","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1161\/CIRCULATIONAHA.106.646380","article-title":"Noninvasive vascular cell adhesion molecule-1 imaging identifies inflammatory activation of cells in atherosclerosis","volume":"114","author":"Nahrendorf","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.molmed.2013.12.001_bib0485","doi-asserted-by":"crossref","first-page":"4725","DOI":"10.1021\/jm9002654","article-title":"Magnetic resonance molecular imaging of vascular cell adhesion molecule-1 expression in inflammatory lesions using a peptide-vectorized paramagnetic imaging probe","volume":"52","author":"Burtea","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.molmed.2013.12.001_bib0490","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.atherosclerosis.2006.08.049","article-title":"LipoCardium: endothelium-directed cyclopentenone prostaglandin-based liposome formulation that completely reverses atherosclerotic lesions","volume":"193","author":"Bittencourt","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.molmed.2013.12.001_bib0495","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1021\/mp4001124","article-title":"Anti-VCAM-1 and anti-E-selectin SAINT-O-Somes for selective delivery of siRNA into inflammation-activated primary endothelial cells","volume":"10","author":"Kowalski","year":"2013","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.molmed.2013.12.001_bib0500","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.biomaterials.2007.09.023","article-title":"Endothelial targeting of semi-permeable polymer nanocarriers for enzyme therapies","volume":"29","author":"Dziubla","year":"2008","journal-title":"Biomaterials"},{"key":"10.1016\/j.molmed.2013.12.001_bib0505","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.bbrc.2013.02.069","article-title":"Detection of early stage atherosclerotic plaques using PET and CT fusion imaging targeting P-selectin in low density lipoprotein receptor-deficient mice","volume":"433","author":"Nakamura","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.molmed.2013.12.001_bib0510","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1194\/jlr.M800405-JLR200","article-title":"Gadolinium-containing phosphatidylserine liposomes for molecular imaging of atherosclerosis","volume":"50","author":"Maiseyeu","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.molmed.2013.12.001_bib0515","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1142\/S1793984410000183","article-title":"Targeting of macrophage foam cells in atherosclerotic plaque using oligonucleotide-functionalized nanoparticles","volume":"1","author":"Sharma","year":"2010","journal-title":"Nano Life"},{"key":"10.1016\/j.molmed.2013.12.001_bib0520","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1021\/mp300316n","article-title":"Interleukin-10: an anti-inflammatory marker to target atherosclerotic lesions via PEGylated liposomes","volume":"10","author":"Almer","year":"2013","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.molmed.2013.12.001_bib0525","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.2147\/IJN.S18739","article-title":"Adiponectin-coated nanoparticles for enhanced imaging of atherosclerotic plaques","volume":"6","author":"Prassl","year":"2011","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.molmed.2013.12.001_bib0530","article-title":"Nanoparticle-mediated delivery of Pitavastatin inhibits atherosclerotic plaque destabilization\/rupture in mice by regulating the recruitment of inflammatory monocytes","author":"Katsuki","year":"2013","journal-title":"Circulation"}],"container-title":["Trends in Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491413002116?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491413002116?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T22:46:51Z","timestamp":1565218011000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471491413002116"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":106,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S1471491413002116"],"URL":"https:\/\/doi.org\/10.1016\/j.molmed.2013.12.001","relation":{},"ISSN":["1471-4914"],"issn-type":[{"value":"1471-4914","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanomedicine-based strategies for treatment of atherosclerosis","name":"articletitle","label":"Article Title"},{"value":"Trends in Molecular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmed.2013.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}